Technology | Market | Products
The company strategy is to focus its R&D efforts on the development of glucose monitoring devices for diabetes patients in order to deliver superior to the existing products.
Upon obtaining sufficient clinical data ABOYA immediately will embark into negotiations with potential marketing and sales partners, allowing a fast market penetration on a global basis.
ABOYA will neither establish a large production facility nor will we
implement a global sales force to reach end customers directly. Instead we
will seek for contracts with global providers in the body glucose monitoring
market. It will depend on negotiations outcome whether the production will be
managed by
ABOYA or by partners.